Dr. Jeffrey Miller, MD
Claim this profileEmory Saint Joseph's Hospital
Studies Depression
Studies Blood Loss
10 reported clinical trials
14 drugs studied
Affiliated Hospitals
Clinical Trials Jeffrey Miller, MD is currently running
AGN1 LOEP SV Kit
for VCFs
This trial is testing a new device called the AGN1 LOEP SV Kit for patients with painful spinal fractures. The device works by stabilizing the broken bone in the spine to reduce pain.
Recruiting1 award N/A
Edwards PASCAL System
for Tricuspid Regurgitation
This trial tests a new device that fixes a leaky heart valve without surgery in patients who are too risky for traditional surgery. The device helps the valve close properly to stop blood from leaking backward. The first device specifically designed for this purpose is the paravalvular leak device (PLD - Occlutech).
Recruiting1 award N/A6 criteria
More about Jeffrey Miller, MD
Clinical Trial Related3 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Jeffrey Miller, MD has experience with
- DrugSorb-ATR System
- Sham Comparator
- Celecoxib
- Edwards PASCAL System
- Optimal Medical Therapy
- Ketamine
Breakdown of trials Jeffrey Miller, MD has run
Depression
Blood Loss
Postoperative Hemorrhage
Bleeding
Surgical Bleeding
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Jeffrey Miller, MD specialize in?
Is Jeffrey Miller, MD currently recruiting for clinical trials?
Are there any treatments that Jeffrey Miller, MD has studied deeply?
What is the best way to schedule an appointment with Jeffrey Miller, MD?
What is the office address of Jeffrey Miller, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.